MedTrace Logo

Quality of Life and Psychological Well-being in Patients With Malignant Melanoma

NCT00963261 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2010-06-25

No results posted yet for this study

Summary

The purpose of this study is to analyse the physical and psychological side-effects in the course of treatment with IFN-alpha. The effectiveness of a specific intervention for the management of these side-effects is evaluated.

Conditions

  • Malignant Melanoma

Interventions

BEHAVIORAL

psycho-oncological intervention

stepped care treatment program with different elements (patient information, exercise, psychoeducation, individual and group therapy, psycho-pharmacology)

Sponsors & Collaborators

  • Essex Pharma GmbH

    collaborator INDUSTRY

  • Universitätsklinikum Köln

    collaborator OTHER

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Katrin Reuter, PhD · University Medical Center Freiburg, Department of Psychiatry and Psychotherapy

  • Dorothee Nashan, MD · University Medical Center, Department of Dermatology

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2011-02-28
Completion
2012-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963261 on ClinicalTrials.gov